58
Participants
Start Date
November 1, 2022
Primary Completion Date
April 28, 2024
Study Completion Date
April 28, 2024
Phases 1 and 2
Phase 1 participants will help inform the cultural adaptation of the study design and materials. Phase 2 will enroll 10 dyads (20 individuals) of AN/AI people who smoke and a family member. Dyad participants will help beta-test the feasibility and acceptability of the financial incentives intervention.
Mayo Clinic, Rochester
Lead Sponsor
National Institute on Drug Abuse (NIDA)
NIH
Alaska Native Tribal Health Consortium
OTHER
Mayo Clinic
OTHER